US Appellate Court boosts “Diagnose and Treat” claims

Journal of Intellectual Property Law & Practice, jpy091,  https://doi.org/10.1093/jiplp/jpy091 Abstract Vanda Pharmaceuticals Inc v West-Ward Pharmaceuticals, US Court of Appeals for the Federal Circuit, 126 USPQ2d 1266 (2018), 13 April 2018   The US Court of Appeals for the Federal Circuit clarified that, at least in special circumstances, a‘diagnose and treat’claim is both patent-eligible and […]

Congratulations to Charles Macedo on being named again to IAM Strategy 300

The world’s pre-eminent IP strategists have been named in the latest edition of IAM Strategy 300 – The World’s Leading IP Strategists, published online by IAM and free to access. The unique guide lists the individuals that in-depth research, undertaken by a team based in London, Washington DC and Hong Kong, has shown to possess […]

In The Press:IPWATCHDOG Turns To Partner Charles R. Macedo For Insight on SAS Institute Decision

SAS: When the Patent Office institutes IPR it must decide patentability of all challenged claims By Gene Quinn & Renee C. Quinn  Yesterday the United States Supreme Court issued decisions in both Oil States v. Green Energyand SAS Institute v. Iancu. In Oil States the Supreme Court upheld the constitutionality of inter partes review (see here, here and here). In SAS Institute, a 5-4 majority […]